Sartorius AG (XTER:SRT3)
€ 217.8 -3.5 (-1.58%) Market Cap: 13.73 Bil Enterprise Value: 17.64 Bil PE Ratio: 58.42 PB Ratio: 4.51 GF Score: 91/100

Q3 2023 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript

Oct 19, 2023 / 10:30AM GMT
Release Date Price: €257.5 (+1.30%)
Operator

Good day, and welcome to the Sartorius and Sartorius Stedim Biotech conference call on the 9 months 2023 results. Today's conference is being recorded.

At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO of Sartorius Group. Please go ahead, sir.

Joachim Kreuzburg
Sartorius Aktiengesellschaft - Chairman of Executive Board, CEO & Interim CFO

Thank you very much and also hello and good day from my side. As always, I would like to kick it off by walking you through the highlights of the past 3 months and the 9 months of 2023, and then Rainer will walk you through the detailed financial results for the Sartorius Group. And then after that, Rene, CEO of Sartorius Stedim Biotech, will talk about the Sartorius Stedim Biotech numbers and therefore, also highlighting the bioprocessing business in more detail as well.

So again, let me start by talking about the most important point over the last couple of months and weeks. So obviously, and I think everyone is following the industry quite closely and seeing also the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot